Bile Duct Diseases

Explore clinical trials studying Bile Duct Diseases. Study availability and eligibility vary by location and protocol.

667 public trials 130 recruiting studies

Refine in advanced search Browse all conditions

Bile Duct Diseases trial results

Active, Not Recruiting

Tempus Priority Study: A Pan-tumor Observational Study

NCT05179824

Conditions: Adnexal Diseases, Bile Duct Diseases, Bile Duct Neoplasms, +113 more
Locations: UT Southwestern Dallas, Texas, United States

Baylor College of Medicine Houston, Texas, United States

View Trial Details

Active, Not Recruiting

S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)

NCT06026865

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations: Department of Hepatology, Transplantology and Internal Medicine, Medical University of Warsaw Warsaw, Poland

View Trial Details

Active, Not Recruiting

Disease Status in Primary Sclerosing Cholangitis by Elastography

NCT02446665

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +11 more
Locations: University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment.

NCT06604923

Conditions: Bezafibrate, Bile Duct Diseases, Biliary Tract Diseases, +12 more
Locations: The Department of Hepatology and Gastroeneterology Aarhus University Hospital. Aarhus, Denmark

View Trial Details

Active, Not Recruiting

norUrsodeoxycholic Acid vs Placebo in PSC

NCT03872921

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations: Medical University of Vienna, Department of Internal Medicine III Vienna, Austria

Medical School Hannover Hanover, Lower Saxonia, Germany

View Trial Details

Active, Not Recruiting

Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH

NCT02997878

Conditions: Autoimmune Diseases, Bile Duct Diseases, Biliary Tract Diseases, +8 more
Locations: University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, West Midlands, United Kingdom

View Trial Details

Active, Not Recruiting

sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis

NCT02924701

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +11 more
Locations: Department of Hepatology and Gastroenterology, Aarhus University Hospital, Denmark Aarhus C, Central Jutland, Denmark

View Trial Details

Bile Duct Diseases

Bile Duct Diseases trial results

Tempus Priority Study: A Pan-tumor Observational Study

S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)

Disease Status in Primary Sclerosing Cholangitis by Elastography

PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment.

norUrsodeoxycholic Acid vs Placebo in PSC

Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH

sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis

Related conditions